You have 9 free searches left this month | for more free features.

selumetinib

Showing 26 - 50 of 50

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC (NSCLC) Trial in Tainan, Taipei (selumetinib)

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • selumetinib
  • Tainan, Taiwan
  • +2 more
Jul 9, 2018

Malignant Tumor of Respiratory and Intrathoracic Organ Carcinoma, Advanced Lung Cancer, Recurrent Nonsmall Cell Lung Cancer

Withdrawn
  • Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma
  • +2 more
  • Selumetinib
  • +2 more
  • (no location specified)
Mar 14, 2018

Breast Cancer Trial in Belgium, Switzerland (fulvestrant, selumetinib)

Completed
  • Breast Cancer
  • Ghent, Belgium
  • +16 more
May 13, 2019

Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV Trial in United Kingdom (selumetinib, gemcitabine, cisplatin)

Completed
  • Locally Advanced or Metastatic NSCL Cancer Stage IIIB IV
  • selumetinib
  • +4 more
  • Glasgow, United Kingdom
  • +3 more
Mar 12, 2018

Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial

Completed
  • Recurrent Thyroid Gland Carcinoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Tampa, Florida
  • +5 more
Dec 2, 2016

Inoperable Locally Advanced or Metastatic Biliary Tract Cancer Trial in Kashiwa Shi, Chuo Ku (Cisplatin, Gemcitabine,

Terminated
  • Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
  • Kashiwa Shi, Chiba, Japan
  • +1 more
May 5, 2016

Biliary Tract Tumors, Cholangiocarcinoma, Gallbladder Tumors Trial in London, Manchester (selumetinib, gemcitabine, cisplatin)

Completed
  • Biliary Tract Neoplasms
  • +2 more
  • selumetinib
  • +2 more
  • London, United Kingdom
  • +2 more
May 11, 2016

Liver and Intrahepatic Biliary Tract Cancer, Recurrent Extrahepatic Bile Duct Cancer, Unresectable Extrahepatic Bile Duct Cancer

Completed
  • Liver and Intrahepatic Biliary Tract Cancer
  • +2 more
  • selumetinib
  • laboratory biomarker analysis
  • Tampa, Florida
  • +6 more
Mar 22, 2016

Adult Solid Tumor Trial in Baltimore (biological, other, drug)

Completed
  • Adult Solid Neoplasm
  • Cixutumumab
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Jan 22, 2016

Adult Solid Tumor Trial in Boston, Charlestown, New York (Selumetinib)

Completed
  • Adult Solid Neoplasm
  • Selumetinib
  • Boston, Massachusetts
  • +4 more
Dec 10, 2015

Solid Tumours Trial in Overland Park (Selumetinib, Moxifloxacin, selumetinib )

Completed
  • Solid Tumours
  • Selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Oct 7, 2015

Recurrent Adult Diffuse Large Cell Lymphoma Trial in United States (Laboratory Biomarker Analysis, Selumetinib)

Terminated
  • Recurrent Adult Diffuse Large Cell Lymphoma
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Chicago, Illinois
  • +15 more
Jan 4, 2016

Solid Tumours Trial in Overland Park (selumetinib, itraconazole, fluconazole)

Completed
  • Solid Tumours
  • selumetinib
  • +2 more
  • Overland Park, Kansas
    Research Site
Jun 29, 2015

Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma Trial in United

Completed
  • Recurrent Adult Soft Tissue Sarcoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Beverly Hills, California
  • +7 more
Sep 4, 2015

Solid Tumours Trial in Orlando (selumetinib)

Completed
  • Solid Tumours
  • selumetinib
  • Orlando, Florida
    Research Site
Jun 29, 2015

Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Promyelocytic Leukemia (M3), MDS Trial in Chicago (selumetinib)

Completed
  • Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)
  • +5 more
  • selumetinib
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jul 6, 2015

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Laboratory Biomarker Analysis,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • Selumetinib
  • Tampa, Florida
  • +8 more
Jul 24, 2015

Recurrent Melanoma, Stage III Skin Melanoma, Stage IV Skin Melanoma Trial in New York (Laboratory Biomarker Analysis,

Completed
  • Recurrent Melanoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Selumetinib
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 16, 2015

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (Akt

Completed
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Tucson, Arizona
  • +533 more
Feb 10, 2016

Healthy Volunteers Pharmacokinetic Study Trial in London (Selumetinib)

Completed
  • Healthy Volunteers Pharmacokinetic Study
  • Selumetinib
  • London, United Kingdom
    Research Site
May 30, 2014

Solid Tumours Trial in Overland Park (selumetinib, rifampicin)

Completed
  • Solid Tumours
  • Overland Park, Kansas
    Research Site
Apr 28, 2014

Recurrent Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma Trial in United States (Akt inhibitor MK2206, selumetinib,

Terminated
  • Recurrent Melanoma
  • +4 more
  • Akt inhibitor MK2206
  • +2 more
  • Atlanta, Georgia
  • +3 more
May 16, 2014

Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer

Completed
  • Adult Primary Hepatocellular Carcinoma
  • +3 more
  • selumetinib
  • pharmacological study
  • Tampa, Florida
  • +5 more
May 12, 2014

Mucosal Melanoma, Recurrent Melanoma, Stage IV Melanoma Trial in Tampa (temsirolimus, selumetinib, laboratory biomarker

Terminated
  • Mucosal Melanoma
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Apr 29, 2014